Author name: TB Alliance

The deadly disease tuberculosis gains a new foe today, a global partnership to develop fast-acting anti-TB drugs. The Global Alliance

After a 30-year void that saw no significant advances in antituberculosis drug development, scientists report the successful preliminary testing of

Some 120 representatives from academia, industry, major agencies, non-governmental organizations and donors gathered in Cape Town to explore need for